Navigation Links
GENova appoints Director of Asian business development

NEW YORK, Sept. 9 /PRNewswire-FirstCall/ - (OTCBB: GVBP.OB) - GENova Biotherapeutics, Inc., ("GENova"), a biotechnology company that identifies, acquires, and develops novel drug targets that disrupt the advance of life-threatening diseases, today announced it has hired Mr. Huynho Jin to lead its business expansion in Asia.

Mr. Jin is a respected Korean business man with extensive experience in establishing and managing business operations throughout South East Asia.

"Asia is a lucrative, but often difficult-to-penetrate market due to its strong reliance on personal relationships," says Aaron Whiteman, CEO for GENova. "Mr. Jin's connections and experience in the region will be a boon for GENova. Thanks to Mr. Jin, we now have personal access to hundreds of Asian biotech startups and their promising new drug technologies."

Previously, Mr. Jin was in charge of expanding operations for Bohun Management throughout Asia. He is reputed for his management and negotiation skills, as well as his strong personal business network throughout South East Asia. Mr. Jin will grow GENova's scientific network in Asia, adding to its existing close relationships with research institutions and biotech startups in the UK, U.S., India, Spain, and Denmark.

About GENova Biotherapeutics Inc.

GENova is positioning itself as the world's leading bioscience company in the development and commercial licensing of novel therapeutic proteins that disrupt the advance of life-threatening cancers. The company leverages cutting-edge research collaborations to achieve breakthroughs in anti-cancer treatments, and then licenses these patented drug product candidates to Big Pharmaceutical and Biotechnology companies.

Forward Looking Statements

This document includes certain statements that may be deemed to be "forward-looking statements" within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical fact, are expected by the Company to be forward-looking statements. Although GENova believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in the forward-looking statements. Factors that could cause actual results to differ materially from those in forward-looking statements include but are not limited to the success of the owned intellectual property, the strength of the patents, continued availability of capital and financing, and general economic market or business conditions.

SOURCE GENova Biotherapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. GENova names Aaron Whiteman as CEO
2. GENova names Dr. John Savin as Vice President
3. Genova files patent for new prostate cancer treatment
4. GENova appoints Dr. Anders Boegh Jensen to Scientific Advisory Board
5. GENova discusses development of new anti-cancer biotechs potentially worth $400 Million per annum
6. WorldHeart Appoints David Pellone Chief Financial Officer
7. Novo Nordisk Appoints New Leader of North American Business
8. Millstone Medical Outsourcing Appoints Operations Manager of New Memphis, TN, Facility
9. China Holdings Appoints Ronald Shon Chairman of Advisory Board to Its Wholly-Owned Subsidiary China Power, Inc.
10. Resonant Medical Appoints New Vice President of Global Sales
11. Response Biomedical appoints S. Wayne Kay Chief Executive Officer
Post Your Comments:
(Date:10/13/2015)... Angeles, CA (PRWEB) , ... October 13, 2015 , ... ... To incentivize would-be customers, eMarketing Concepts began a $1 promotion – effectively offering all ... a resounding success, and within weeks the company was flooded with phone calls from ...
(Date:10/13/2015)... ... 13, 2015 , ... The Bill Howe Family of Companies is an award ... and flood remediation services. Family-owned and operated for 35 years, they have maintained value, ... Diego plumber two years in a row from the Union Tribune Reader’s Poll, a ...
(Date:10/12/2015)... , ... October 13, 2015 , ... ... its biannual Heroes in Recovery Awards at Foundations Recovery Network’s Moments of Change ... presented the one-of-a-kind awards to Noah Levine and Dean Dauphinais who exemplify the ...
(Date:10/12/2015)... North Carolina (PRWEB) , ... October 12, 2015 , ... Kevin Costello, winner of the ... North Carolina , embarks today for his dream vacation to Hawaii. , “I didn’t believe ... worked out,” he says. “This contest encouraged me to get to the gym and invest ...
(Date:10/12/2015)... ... 2015 , ... The American Society of Clinical Hypnosis (ASCH) ... and clinical training in a health care discipline. , Many practitioners claim ... losing weight, managing pain, or stopping smoking, etc. Frequently, extravagant statements and guarantees ...
Breaking Medicine News(10 mins):
(Date:10/12/2015)... LONDON , Oct. 12, 2015 ... eye, it is quite challenging to deliver an ophthalmic drug ... be overcome for a successful ocular drug delivery. These include ... by the lymphatic system of conjunctiva and drug permeation issues ... of the drug, in topical eye drops, is lost due ...
(Date:10/12/2015)... Oct. 12, 2015  The Pharmacy Compounding Accreditation ... Compounding Pharmacy in Costa Mesa ... of the pharmacy,s commitment to meeting and/or exceeding ... --> --> ... --> --> Harbor ...
(Date:10/12/2015)... 2015  MiMedx Group, Inc. (NASDAQ: MDXG ), ... and patent-protected processes to develop and market advanced products ... Sports Medicine, Ophthalmic, and the Dental sectors of healthcare, ... quarter of 2015, its guidance for the fourth quarter ... $50 million Senior Secured Credit Facility. ...
Breaking Medicine Technology: